A detailed history of Focused Wealth Management, Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Focused Wealth Management, Inc holds 5,336 shares of NVO stock, worth $453,560. This represents 0.09% of its overall portfolio holdings.

Number of Shares
5,336
Previous 5,366 0.56%
Holding current value
$453,560
Previous $765,000 16.99%
% of portfolio
0.09%
Previous 0.11%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

SELL
$119.07 - $145.42 $3,572 - $4,362
-30 Reduced 0.56%
5,336 $635,000
Q2 2024

Jul 30, 2024

BUY
$122.71 - $146.91 $47,611 - $57,001
388 Added 7.79%
5,366 $765,000
Q1 2024

May 08, 2024

BUY
$102.11 - $135.92 $506,465 - $674,163
4,960 Added 27555.56%
4,978 $639,000
Q3 2023

Nov 01, 2023

BUY
$90.94 - $199.54 $818 - $1,795
9 Added 100.0%
18 $1,000
Q2 2023

Aug 08, 2023

BUY
$155.98 - $172.65 $1,403 - $1,553
9 New
9 $1,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $192B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Focused Wealth Management, Inc Portfolio

Follow Focused Wealth Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Focused Wealth Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Focused Wealth Management, Inc with notifications on news.